• 熔點(diǎn)： 184-186 °C

• 沸點(diǎn)： 1015.8±65.0 °C(Predicted)

• 外觀： 黃色粉末

• 溶解性： DMSO  :  ≥  34  mg/mL  (55.51  mM)

• 儲(chǔ)存條件： 2-8℃

• 注意：部分產(chǎn)品我司僅能提供部分信息，我司不保證所提供信息的權(quán)威性，僅供客戶參考交流研究之用。

• 88. [5.3] Li Teng et al."Metabolomics integrated with network pharmacology of blood-entry constituents reveals the bioactive component of Xuefu Zhuyu decoction and its angiogenic effects in treating traumatic brain injury."Chinese Medicine.2024 Dec;19(1):1-16

• 87. [6] Yi-Fang Gao et al."The profile of plant bioactive compounds in Xinjiang, China unifloral safflower honey and their inhibitory on ACE, and determination of the mechanism of inhibition."LWT-FOOD SCIENCE AND TECHNOLOGY.2024 Oct;210:116806

• 86. [1.9] Shibiao Ding et al."Safflower Alleviates Pulmonary Arterial Hypertension by Inactivating NLRP3: A Combined Approach of Network Pharmacology and Experimental Verification."Clinical Respiratory Journal.2024 Aug;18(8):e13826

• 85. [7.1] Li Ning et al."Transplantation of human endometrial perivascular stem cells with hydroxy saffron yellow A promotes uterine repair in rats."Stem Cell Research & Therapy.2024 Dec;15(1):1-15

• 84. [6.7] Wenxuan Wang et al."Hydroxysafflor yellow A ameliorates alcohol-induced liver injury through PI3K/Akt and STAT3/NF-κB signaling pathways."PHYTOMEDICINE.2024 Jun;:155814

• 83. [IF=8.6] Kai-Yu Ruan et al."Bio-derived solvent based salt-responsive system for simultaneous extraction and in-situ enrichment of polysaccharides and phenolics from Carthamus tinctorius L. flower."SEPARATION AND PURIFICATION TECHNOLOGY".2024 Dec;349:127795

• 82. [IF=5.4] Yang Wang et al."Buyang huanwu decoction promotes remyelination via miR-760-3p/GPR17 axis after intracerebral hemorrhage."JOURNAL OF ETHNOPHARMACOLOGY".2024 Jun;328:118126

• 81. [IF=5.4] Yanqiu Sun et al."Network pharmacology integrated with experimental validation revealed the mechanism of Fengshi Gutong Capsule in the treatment of osteoarthritis."JOURNAL OF ETHNOPHARMACOLOGY.2023 Oct;:117261

• 80. [IF=5.4] Menghan Cheng et al."A novel strategy of integrating network pharmacology and transcriptome reveals antiapoptotic mechanisms of Buyang Huanwu Decoction in treating intracerebral hemorrhage."JOURNAL OF ETHNOPHARMACOLOGY.10.1016/j.jep.2023.117123

• 79. [IF=3.8] En Hu et al."Metabolomics reveals the effects of hydroxysafflor yellow A on neurogenesis and axon regeneration after experimental traumatic brain injury."PHARMACEUTICAL BIOLOGY.2023;61(1):1054-1064

• 78. [IF=5.4] Dandan Feng et al."N6-methyladenosine profiling reveals that Xuefu Zhuyu decoction upregulates METTL14 and BDNF in a rat model of traumatic brain injury."JOURNAL OF ETHNOPHARMACOLOGY.2023 Dec;317:116823

• 77. [IF=6] Rong-Shuai Hu et al."Comparative study on optimization of NADES extraction process by dual models and antioxidant activity of optimum extraction from Chuanxiong-Honghua."LWT-FOOD SCIENCE AND TECHNOLOGY.2023 Jul;184:114991

• 76. [4.46] Jiaxi Chen et al."Hydroxysafflor yellow A protects against colitis in mice by suppressing pyroptosis via inhibiting HK1/NLRP3/GSDMD and modulating gut microbiota."TOXICOLOGY AND APPLIED PHARMACOLOGY.2023 May;467:116494

• 75. [5.195] Zelin Lai et al."Hydroxysafflor yellow a confers neuroprotection against acute traumatic brain injury by modulating neuronal autophagy to inhibit NLRP3 inflammasomes."JOURNAL OF ETHNOPHARMACOLOGY.2023 May;308:116268

• 74. [0] Xiaoqing Song et al."Protective effect of hydroxysafflor yellow A on MSCs against senescence induced by D-galactose."Chinese Herbal Medicines.2022 Dec;:

• 73. [1.698] Mengjie Xue et al."Illumination on Chemical Compounds from Qufeng Zhitong Capsule and Its Potential Pharmacological Mechanism against Rheumatoid Arthritis Based on UHPLC/Q-Orbitrap-MS Combined with Network Pharmacology Analysis."International Journal of A

• 72. [6.656] Jiling Feng et al."Luhong Formula and Hydroxysafflor yellow A protect cardiomyocytes by inhibiting autophagy."PHYTOMEDICINE.2023 Feb;110:154636

• 71. [7.425] Zhen Yan et al."Composition of major quinochalcone hydroxysafflor yellow A and anhydrosafflor yellow B is associated with colour of safflower (Carthamus tinctorius) during colour-transition but not with overall antioxidant capacity: a study on 144 cultiva

• 70. [IF=2.65] Jing Zhou et al."Buyang Huanwu Decoction: A Traditional Chinese Medicine, Promotes Lactate-Induced Angiogenesis in Experimental Intracerebral Hemorrhage."Evidence-based Complementary and Alternative Medicine.2022 Oct 30;2022:4063315

• 69. [IF=7.419] Yule Wang et al."Discovery of anti-stroke active substances in Guhong injection based on multi-phenotypic screening of zebrafish."BIOMEDICINE & PHARMACOTHERAPY.2022 Nov;155:113744

• 68. [IF=2.464] Zhou Huifen et al."Pharmacokinetic-Pharmacodynamic Modeling of Active Components from Salvia miltiorrhiza (Danshen) and Carthamus tinctorius (Honghua) in Focal Cerebral Ischemia Rats."Revista Brasileira de Farmacognosia-Brazilian Journal of Pharmacognosy.

• 67. [IF=6.53] Qianqian Chen et al."Pharmacokinetic-pharmacodynamic modeling analysis for hydroxysafflor yellow A-calycosin in compatibility in normal and cerebral ischemic rats: A comparative study."Biomed Pharmacother. 2022 Jun;150:112950

• 66. [IF=3.269] Dan Su et al."Hydroxysafflor yellow A inhibits the proliferation, migration, and invasion of colorectal cancer cells through the PPARγ/PTEN/Akt signaling pathway."Bioengineered. 2021;12(2):11533-11543

• 65. [IF=6.529] Ting Shang et al."The combination of four main components in Xuebijing injection improved the preventive effects of Cyclosporin A in acute graft-versus-host disease mice by protecting intestinal microenvironment."Biomed Pharmacother. 2022 Apr;148:112675

• 64. [IF=5.34] Yule Wang et al."Guhong injection promotes post-stroke functional recovery via attenuating cortical inflammation and apoptosis in subacute stage of ischemic stroke."Phytomedicine. 2022 May;99:154034

• 63. [IF=0.533] Jinyan Jiang et al."Comparative studies of the anti-thrombotic effects of saffron and HongHua based on network pharmacology."Trop J Pharm Res. 2020 Nov;19(7):1441-1448

• 62. [IF=1.902] Rui Yao et al."Pharmacokinetic characteristics of hydroxysafflor yellow A in normal and diabetic cardiomyopathy mice."Biomed Chromatogr. 2021 Oct;35(10):e5173

• 61. [IF=1.902] Ting Zhang et al."The influence of essential oils from ZhaLi NuSi Prescription on the pharmacokinetics of its non-volatile components in normal rats."Biomedical Chromatography. 2021 Oct 21

• 60. [IF=3] Qu Lala et al."Phenotypic assessment and ligand screening of ETA/ETB receptors with label-free dynamic mass redistribution assay."N-S Arch Pharmacol. 2020 Jun;393(6):937-950

• 59. [IF=3.098] Donglai Zhou et al."Hydroxysafflor Yellow A mitigated myocardial ischemia/reperfusion injury by inhibiting the?activation of the JAK2/STAT1 pathway."Int J Mol Med. 2019 Aug;44(2):405-416

• 58. [IF=4.225] Shang Ting et al."Xuebijing Injection Maintains GRP78 Expression to Prevent Candida albicans–Induced Epithelial Death in the Kidney."Front Pharmacol. 2020 Jan;0:1416

• 57. [IF=4.36] Li Lin et al."Study on the alleviation of Fengshi Gutong capsule on rheumatoid arthritis through integrating network pharmacology and experimental exploration."J Ethnopharmacol. 2021 Nov;280:114471

• 56. [IF=4.545] Na Wu et al."Hydroxysafflor yellow A promotes apoptosis via blocking autophagic flux in liver cancer."Biomed Pharmacother. 2021 Apr;136:111227

• 55. [IF=5.34] Jing Zhang et al."Application of “spider-web” mode in discovery and identification of Q-markers from Xuefu Zhuyu capsule."Phytomedicine. 2020 Oct;77:153273

• 54. [IF=5.81] Fangma Yijia et al."Hydroxysafflor Yellow A and Anhydrosafflor Yellow B Protect Against Cerebral Ischemia/Reperfusion Injury by Attenuating Oxidative Stress and Apoptosis via the Silent Information Regulator 1 Signaling Pathway."Front Pharmacol. 2021 Sep

• 53. [IF=7.271] Teng Li et al."Integrated metabolomics and network pharmacology to reveal the mechanisms of hydroxysafflor yellow A against acute traumatic brain injury."Comput Struct Biotec. 2021 Jan;19:1002

• 52. [IF=7.514] Xin Tong et al."Greener extraction process and enhanced in vivo bioavailability of bioactive components from Carthamus tinctorius L. by natural deep eutectic solvents."Food Chem. 2021 Jun;348:129090

• 51. [IF=7.514] Liuwei Zhao et al."Safflomin A: A novel chemical marker for Carthamus tinctorius L. (Safflower) monofloral honey."Food Chem. 2022 Jan;366:130584

• 50. [IF=2.1] Bin Ni et al."Hydroxysafflor yellow A protects against angiotensin II?induced hypertrophy."Mol Med Rep. 2018 Oct;18(4):3649-3656

• 49. [IF=2.173] Wenlu Li et al."Hydroxysafflor yellow A protects methylglyoxal-induced injury in the cultured human brain microvascular endothelial cells."Neurosci Lett. 2013 Aug;549:146

• 48. [IF=2.233] Zhenzhen Ni et al."Inhibitory effects of hydroxysafflor yellow A on the formation of advanced glycation endproducts in vitro."Biological & Pharmaceutical Bulletin. 2012 Aug 31

• 47. [IF=2.547] Jing Zhou et al."Pharmacokinetic Study on Protocatechuic Aldehyde and Hydroxysafflor Yellow A of Danhong Injection in Rats with Hyperlipidemia."Pharmacology. 2018;102(3-4):154-160

• 46. [IF=2.896] Lu Wang et al."Rapid assay for testing superoxide anion radical scavenging activities to natural pigments by ultra-high performance liquid chromatography-diode-array detection method."Anal Methods-Uk. 2015 Feb;7(4):1535-1542

• 45. [IF=3.046] Liwei Dong et al."Echinacoside induces apoptotic cancer cell death by inhibiting the nucleotide pool sanitizing enzyme MTH1."Oncotargets Ther. 2015; 8: 3649–3664

• 44. [IF=3.845] Zhang Xianhua et al."Danshen-Chuanxiong-Honghua Ameliorates Cerebral Impairment and Improves Spatial Cognitive Deficits after Transient Focal Ischemia and Identification of Active Compounds."Front Pharmacol. 2017 Jul;0:452

• 43. [IF=5.81] Yu Li et al."Pharmacokinetics of Active Components From Guhong Injection in Normal and Pathological Rat Models of Cerebral Ischemia: A Comparative Study."Front Pharmacol. 2018 May;0:493

• 42. [IF=10.618] Yao-Xiong Huang et al."Versatile on-stage microfluidic system for long term cell culture, micromanipulation and time lapse assays."Biosens Bioelectron. 2018 Mar;101:66

• 41. Zhang, Jing, et al. "Application of “spider-web” mode in discovery and identification of Q-markers from Xuefu Zhuyu capsule." Phytomedicine 77 (2020): 153273.https://doi.org/10.1016/j.phymed.2020.153273

• 40. Jiang, Jinyan, et al. "Comparative studies of the anti-thrombotic effects of saffron and HongHua based on network pharmacology." Tropical Journal of Pharmaceutical Research 19.7 (2020): 1441-1448.https://doi.org/10.4314/tjpr.v19i7.16

• 39. Yu, Lu, et al. "Hydroxysafflor yellow a confers neuroprotection from focal cerebral ischemia by modulating the crosstalk between JAK2/STAT3 and SOCS3 signaling pathways."?Cellular and molecular neurobiology?(2020): 1-11.

• 38. Zhou, Donglai, et al. "Hydroxysafflor Yellow A mitigated myocardial ischemia/reperfusion injury by inhibiting the activation of the JAK2/STAT1 pathway." International journal of molecular medicine 44.2 (2019): 405-416.https://doi.org/10.3892/ijmm.2019.4230

• 37. Wu, Na, et al. "Hydroxysafflor yellow A promotes apoptosis via blocking autophagic flux in liver cancer."?Biomedicine & Pharmacotherapy?136 (2021): 111227.https://doi.org/10.1016/j.biopha.2021.111227

• 36. 黃楷迪,劉敬霞,牛陽,馬學(xué)琴,張婷,卜凡淑,任慧,郭盛,錢大瑋,段金廒.回藥扎里奴思方UPLC指紋圖譜結(jié)合多成分含量測定的質(zhì)控方法研究[J].南京中醫(yī)藥大學(xué)學(xué)報(bào),2021,37(01):77-82.

• 35. 李燕霞,王琳,姚弘毅.HSYA對(duì)骨關(guān)節(jié)炎大鼠膝關(guān)節(jié)軟骨損傷的修復(fù)作用研究[J].局解手術(shù)學(xué)雜志,2021,30(03):195-199.

• 34. 謝飛,周美蘭.羥基紅花黃色素A抑制高糖誘導(dǎo)的小鼠腎足細(xì)胞損傷[J].基礎(chǔ)醫(yī)學(xué)與臨床,2021,41(01):27-32.

• 33. 支旭然 劉洪濤 吳茵 等. UPLC-MS/MS法同時(shí)測定腎康注射液中7個(gè)有效成分[J]. 藥物分析雜志 2017 037(001):37-42.

• 32. 李正, 潘萬芳, 朱立明,等. 基于物質(zhì)流分析的丹紅注射液制藥過程質(zhì)量控制研究[J]. 天津中醫(yī)藥大學(xué)學(xué)報(bào), 2015, 34(06):349-352.

• 31. 支旭然 董占軍 吳茵 等. HPLC同時(shí)測定腎康注射液中的4種成分[J]. 華西藥學(xué)雜志 2017(03):297-299.

• 30. 黃趙剛, 程鋼, 湯浩,等. 血必凈注射液指紋圖譜研究[J]. 中國醫(yī)院藥學(xué)雜志, 2018, 038(022):2323-2327.

• 29. 艾進(jìn)超 何昱 楊榮兵 等. 丹紅注射液中主要有效成分在腦缺血大鼠體內(nèi)藥動(dòng)學(xué)研究[J]. 中草藥 2015 46(20):79-84.

• 28. 劉雪 石曉倩 吳晏杰 等. UPLC法同時(shí)測定新安名方腦絡(luò)欣通中5個(gè)活性成分的含量[J]. 貴陽中醫(yī)學(xué)院學(xué)報(bào) 2020年42卷4期 26-31頁 ISTIC 2020.

• 27. 馬夢雪 吳士筠 李剛 等. HPLC法同時(shí)測定不同品種紅花中4種黃酮類[J]. 中成藥 2019 041(011):2694-2700.

• 26. 方雨晨, 萬海同, 虞立,等. 谷紅注射液主要有效成分在腦缺血模型大鼠體內(nèi)的藥動(dòng)學(xué)研究[J]. 中國中藥雜志, 2018, 043(009):1940-1945.

• 25. 王亞洲, 楊春旭. 蝎龍酒質(zhì)量標(biāo)準(zhǔn)研究[J]. 中國實(shí)驗(yàn)方劑學(xué)雜志, 2012, 18(23):105-108.

• 24. 王亞洲. 蝎龍接骨散質(zhì)量標(biāo)準(zhǔn)研究[J]. 黑龍江醫(yī)藥, 2012, 25(6):845-847.

• 23. 易麗娟, 李雅, 鄒蘇蘭,等. 基于正交試驗(yàn)設(shè)計(jì)與BP神經(jīng)網(wǎng)絡(luò)優(yōu)化益氣活血方水提工藝研究[J]. 中草藥, 2019, v.50;No.653(18):50-57.

• 22. 王亞洲. HPLC法同時(shí)測定蝎龍酒中芍藥苷 羥基紅花黃色素A和阿魏酸[J]. 中成藥 2012 34(010):1925-1928.

• 21. 王亞洲 楊春旭. HPLC同時(shí)測定蝎龍接骨散中羥基紅花黃色素A和阿魏酸的含量[J]. 中國實(shí)驗(yàn)方劑學(xué)雜志 2012 18(22):109-111.

• 20. 陳俊奎, 萬海同, 周惠芬,等. 谷紅注射液在腦缺血再灌注大鼠體內(nèi)藥動(dòng)學(xué)與抗氧化作用關(guān)聯(lián)性研究[J]. 中草藥, 2016, 47(003):447-453.

• 19. 施笑暉, 唐映紅, 陳建真,等. 谷紅注射液中羥基紅花黃色素A在大鼠體內(nèi)的藥動(dòng)學(xué)研究[J]. 中成藥, 2015, 037(011):2387-2391.

• 18. 潘璐佳, 萬海同, 陳俊奎,等. 谷紅注射液中2種成分對(duì)腦缺血大鼠氨基酸類神經(jīng)遞質(zhì)釋放的協(xié)同作用[J]. 中成藥, 2019, 041(004):784-788.

• 17. 吳鴻,雷震,高水波,張玲霞,代麗萍.羥基紅花黃色素A通過抑制微小RNA-1表達(dá)對(duì)H9c2心肌細(xì)胞氧化損傷的保護(hù)作用[J].北京中醫(yī)藥大學(xué)學(xué)報(bào),2018,41(08):636-641.

• 16. 萬甜,吳敏瑞,齊振熙.羥基紅花黃色素A對(duì)激素誘導(dǎo)骨髓間充質(zhì)干細(xì)胞成骨分化的影響[J].中國骨傷,2014,27(03):224-228.

• 15. 齊振熙, 吳敏瑞, 萬甜,等. 羥基紅花黃色素A對(duì)激素誘導(dǎo)骨髓間充質(zhì)干細(xì)胞ERK1/2的干預(yù)作用[J]. 康復(fù)學(xué)報(bào), 2014, 24(002):13-16.

• 14. 侯兆陽, 陳哲, 魏家森. 羥基紅花黃色素A對(duì)急性脊髓損傷模型大鼠神經(jīng)細(xì)胞凋亡的影響[J]. 浙江中西醫(yī)結(jié)合雜志, 2014, 000(009):753-756.

• 13. 齊振熙,萬甜,吳敏瑞,張占勇,仲衛(wèi)紅,于濤.羥基紅花黃色素A不同給藥方式對(duì)激素性股骨頭缺血壞死模兔ERK1/2、JNK和p38蛋白表達(dá)的影響[J].中華中醫(yī)藥雜志,2014,29(09):2927-2930.

• 12. 樊啟猛, 劉潤南, 賀鵬,等. 經(jīng)典名方單味藥材群體指紋圖譜信息熵及一次投料量研究[J]. 時(shí)珍國醫(yī)國藥, 2020年31卷4期, 975-979頁, PKU CSCD CA, 2020.

• 11. 萬甜,吳敏瑞,齊振熙.紅花提取物對(duì)激素性股骨頭缺血壞死兔股骨頭組織ERK、JNK和P38蛋白表達(dá)的影響[J].中醫(yī)雜志,2013,54(23):2039-2042.

• 10. 杜紅芳, 耿魁魁, 李冬梅,等. 注射用紅花黃色素與6種輸液配伍的穩(wěn)定性[J]. 中成藥, 2014, 036(008):1635-1640.

• 9. 特日格樂, 韓曉靜, 寶樂爾,等. 正交試驗(yàn)優(yōu)選蒙藥紅花最佳醇提工藝[J]. 智慧健康, 2020, 006(007):47-48.

• 8. 李海英, 賀鵬, 樊啟猛,等. 桃紅四物湯HPLC指紋圖譜的總量統(tǒng)計(jì)矩及一次穩(wěn)態(tài)投料量分析. 中國實(shí)驗(yàn)方劑學(xué)雜志.

• 7. ]賀智勇,鄒弢,羅田,李婉蓉,楊佳佳,劉學(xué),肖婷,周雪,吳林菁,劉文,沈祥春,陶玲.基于薄荷油為油相的紅花提取物自微乳凝膠遞送系統(tǒng)制備研究[J].中草藥,2020,51(11):2922-2928.

• 6. 杜輝 馬永強(qiáng) 李春陽 等. 響應(yīng)面法優(yōu)化復(fù)合酶提取紅花黃色素工藝[J]. 南方農(nóng)業(yè)學(xué)報(bào) 2015 46(004):657-663.

• 5. 范紅晶 虞立 金偉鋒 李敏 周靜 李曉紅 張宇燕.原兒茶醛與羥基紅花黃色素A單用與合用在高脂血癥大鼠體內(nèi)的藥動(dòng)學(xué)-藥效學(xué)相關(guān)性研究[J].中國中藥雜志 2017 42(13):2564-2570.

• 4. 朱振洪 黃小飛 王玉 周郡 潘利峰 萬海同.丹紅注射液與羥基紅花黃色素A對(duì)大鼠腦缺血再灌注后IL-1β、TNF-α和Caspase-3 mRNA表達(dá)的影響[J].中華中醫(yī)藥雜志 2016 31(04):1390-1393.

• 3. 李宵 吳茵 支旭然 等. UPLC-MS/MS同時(shí)測定谷紅注射液中7種有效成分[J]. 中國實(shí)驗(yàn)方劑學(xué)雜志 2017(21):64-69.

• 2. 徐森玲 萬海同 金湛 等. PHPLC法同時(shí)分離純化紅花中2種成分[J]. 中成藥 2017 39(002):436-439.

• 1. 陳娟 周曄 陳偉華 等. ICU超劑量谷紅注射液成品輸液的合理性考察[J]. 臨床合理用藥雜志 2018 11(31):18-21.

輸入產(chǎn)品批號(hào)：

本計(jì)算器可幫助您計(jì)算出特定溶液中溶質(zhì)的質(zhì)量、溶液濃度和體積之間的關(guān)系，公式為：

質(zhì)量 (mg) = 濃度 (mM) x 體積 (mL) x 分子摩爾量 (g/mol)

• pg ng μg mg g kg =
  fM pM nM μM mM M *
  nL μL mL L *